DOI: https://doi.org/10.22263/2312-4156.2023.2.71
A.G. Staravoitau1, F.N. Karpenko2, V.V. Pasyukov2, S.A. Tachyla3,4, A.V. Marochkov3,4
The analysis of blood components consumption in the Mogilev region in 2017-2021
1Mogilev Regional Blood Transfusion Station, Mogilev, Republic of Belarus
2Republican Scientific and Practical Center for Transfusiology and Medical Biotechnologies, Minsk, Republic of Belarus
3Mogilev Regional Clinical Hospital, Mogilev, Republic of Belarus
4Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2023;22(2):71-79.
Abstract.
Objectives. To identify the peculiarities of blood components consumption by hospitals in the Mogilev region during five years and to determine trends in their use in connection with the pandemic of COVID-19 infection.
Material and methods. Retrospectively for 2017-2021, the volumes of transfusion of erythrocyte blood components (EBC), fresh frozen plasma (FFP), the number of transfused doses of platelet blood components (PBC), cryoprecipitate (CP) in hospitals throughout the Mogilev region were studied depending on the number of treated patients, the number of bed-days spent by them in the hospital and the number of cases of COVID-19 infection. Also these indicators were analyzed in a single health care institution “Mogilev Regional Clinical Hospital”, in which in 2020-2021 care to patients with COVID-19 infection was provided.
Results. Consumption of EBC, FFP and CP in 2017-2019 per 1000 inhabitants of the Mogilev region did not change statistically significantly, there was an increase in the use of PBC in 2019 compared to 2017 (p<0.05). In 2020, there was an increase in the consumption of blood components compared to 2017-2019: EBC by 31.7%, PBC by 35.2%, CP by 35.6% from the level of 2017 (p<0.05). In 2021, there was a statistically significant increase in the consumption of blood components compared to 2017-2019: EBC by 27.2%, FFP by 13.9%, PBC by 37%, CP by 23.1% from the level of 2017 (p<0.05). These changes are likely to be related to the 2020-2021 COVID-19 pandemic, which has led to significant changes in the structure of production and clinical use of blood components.
Conclusions. The identified trends require to change the resource capabilities of the regional subjects of the blood service for planning and, if necessary, increasing the procurement of PBC, СP, dry one included, and creating a sufficient donor reserve.
Keywords: consumption of blood components, erythrocyte blood components, fresh frozen plasma, platelet blood components, cryoprecipitate, COVID-19 infection.
References
1. Hollán S, Wagstaff W, Leikola J, Lothe F, red. Management of the blood transfusion service. Geneva, Switzerland: Vsemirnaya organizatsiya zdravookhraneniya, 1993. 224 p. Rezhim dostupa: https://apps.who.int/iris/bitstream/handle/10665/88181/5225019315.pdf?sequence=1&isAllowed=y. Data dostupa: 28.03.2023. (In Russ.)
2. Tankaeva KhS, Abdulaev IA, Khizbulaeva NS, Magomedova KhM, Zhiburt EB. Release and distribution of blood components in Dagestan. Transfuziologiya. 2020;21(1):14-9. (In Russ.)
3. Leshchuk SP, Potapnev MP, Lyakh SA, Lagodich LG. Analysis of the use of blood components in health care organizations of the Republic of Belarus. Zdravookhranenie. 2011;(10):61-5. (In Russ.)
4. Kuznetsov SI, Kudinova EV, Zhiburt EB. Blood procurement during COVID-19 infection. Menedzher Zdravookhraneniya. 2020;(5):40-3. (In Russ.)
5. Medvedeva IV, Kukharevich EI, Vasilevskaya ZhN, Dovnar OA, Tarasyuk NV, Lapkovskaya TV, i dr, red. Statistical Yearbook of the Republic of Belarus 2021. Minsk, RB: Natsional'nyi statisticheskii komitet Respubliki Belarus'; 2021. 407 р. (In Russ.)
6. On some issues related to the donation of blood and its components: postanovlenie Soveta Ministrov Resp Belarus', 02 iyunya 2011 g, № 693. Nats. tsentr pravovoi inform Resp Belarus'. Etalon [Elektronnyi resurs]. Minsk, RB; 2023. (In Russ.)
7. Koçak T, Kayaaslan B, Mer M. COVID-19 and Sepsis. Turk J Med Sci. 2021 Dec;51(SI-1):3301-11. doi: http://dx.doi.org/10.3906/sag-2108-239
8. Helms J, Tacquard Charles, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089-98. doi: http://dx.doi.org/10.1007/s00134-020-06062-x
9. Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020 Oct;142(17):1609-11. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.120.050354
10. Soy M, Atagündüz P, Atagündüz I, Sucak GT. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2021 Jan;41(1):7-18. doi: http://dx.doi.org/10.1007/s00296-020-04636-y
11. Provisional guidelines for prevention, diagnosis and treatment of new coronavirus infection (COVID-19) Version 16 (18.08.2022) [Elektronnyi resurs]. Minzdrav.gov.ru: [sait]. Rezhim dostupa: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/%D0%92%D0%9C%D0%A0_COVID-19_V16.pdf. Data dostupa: 28.03.2023. (In Russ.)
12. On the organization of medical care for patients with COVID-19 infection: prikaz M-va zdravookhraneniya Resp Belarus', 22 iyunya 2022 g, № 841. Nats tsentr pravovoi inform Resp Belarus'. Etalon [Elektronnyi resurs]. Minsk, RB; 2023. (In Russ.)
13. Vaganova TV, Gerasimchik PA. Clinical transfusiology, management of blood components and blood products for patients. Gematologiya Transfuziologiya Vostoch Evropa. 2017;3(4):655-62. (In Russ.)
14. Chechetkin AV, Danilchenko VV, Grigoryan MSh, Vorobey LG, Plotskiy RA. Analysis of the performance of the blood service of the Russian Federation in 2019. Transfuziologiya. 2020;21(3):200-10. (In Russ.)
15. Kleinerüschkamp A, Meybohm P, Straub N, Zacharowski K, Choorapoikayil S. A model-based cost-effectiveness analysis of Patient Blood Management. Blood Transfus. 2019 Jan;17(1):16-26. doi: http://dx.doi.org/10.2450/2018.0213-17
16. Facco G, Bennardello F, Fiorin F, Galassi C, Monagheddu C, Berti P.. A nationwide survey of clinical use of blood in Italy. Blood Transfus. 2021 Sep;19(5):384-95. doi: http://dx.doi.org/10.2450/2021.0083-21
17. Marochkov AV, Lipnitskiy AL, Starovoytov AG, Dozortseva OV, Livinskaya VA. Integrative index of platelet aggregation in intensive care patients with COVID-19 infection. Problemy Zdorov'ya Ekologii. 2021;18(4):99-107. (In Russ.)
18. Starovoytov AG, Lipnitskiy AL, Marochkov AV. Platelet aggregation in donors of platelet mass and fresh frozen plasma. Vestn VGMU. 2021;20(5):42-8. (In Russ.)
Information about authors:
A.G. Staravoitau – valeologist, Mogilev Regional Blood Transfusion Station, https://orcid.org/0000-0001-762-2644
F.N. Karpenko – Candidate of Medical Sciences, Director of the Republican Scientific and Practical Center for Transfusiology and Medical Biotechnologies;
V.V. Pasyukov – Candidate of Biological Sciences, head of the Laboratory of Mechanisms of Cellular Drug Resistance, Republican Scientific and Practical Center for Transfusiology and Medical Biotechnologies;
S.A. Tachyla – Candidate of Medical Sciences, anesthesiologist-resuscitator of the anesthesiology & resuscitation department, Mogilev Regional Clinical Hospital; associate professor of the affiliated branch of the Chairs of Anesthesiology and Resuscitation with the course of the Faculty for Advanced Training & Retraining and Hospital Surgery with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University, https://orcid.org/0000-0003-1659-5902
e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. –Siarhei A. Tachyla;
A.V. Marochkov – Doctor of Medical Sciences, anesthesiologist-resuscitator of the anesthesiology and resuscitation department, Mogilev Regional Clinical Hospital; professor of the affiliated branch of the Chairs of Anesthesiology and Resuscitation with the course of the Faculty for Advanced Training & Retraining and Hospital Surgery with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University, https://orcid.org/0000-0001-5092-8315
